Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5. This reflects a minor update to the page metadata rather than substantive content changes.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating an update to the site's underlying system or documentation. No visible changes to the study details appear to be introduced by this change.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a backend or template update.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study page now references revision v3.6.2 for the protocol/SAP, replacing the previous v3.6.0. This signals a newer version of the study documentation is available for review on the page.SummaryDifference0.0%

- Check78 days agoChange DetectedNew sections such as How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment have been added, while an older Intervention / Treatment heading was removed; the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page revision tag was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor update to the study page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.